GS-5745 Active Not Recruiting Phase 2 Trials for Gastric Adenocarcinoma / Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02864381Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma